Literature DB >> 33402694

Parkinson's disease with restless legs syndrome-an in vivo corneal confocal microscopy study.

Mattias Andréasson1,2,3, Neil Lagali4, Reza A Badian5, Tor Paaske Utheim6, Fabio Scarpa7, Alessia Colonna7, Stephan Allgeier8, Andreas Bartschat8, Bernd Köhler8, Ralf Mikut8, Klaus-Martin Reichert8, Göran Solders9,10,11, Kristin Samuelsson9,10, Henrik Zetterberg12,13,14,15, Kaj Blennow12,13, Per Svenningsson16,9,10.   

Abstract

Small fiber neuropathy (SFN) has been suggested as a trigger of restless legs syndrome (RLS). An increased prevalence of peripheral neuropathy has been demonstrated in Parkinson's disease (PD). We aimed to investigate, in a cross-sectional manner, whether SFN is overrepresented in PD patients with concurrent RLS relative to PD patients without RLS, using in vivo corneal confocal microscopy (IVCCM) and quantitative sensory testing (QST) as part of small fiber assessment. Study participants comprised of age- and sex-matched PD patients with (n = 21) and without RLS (n = 21), and controls (n = 13). Diagnosis of RLS was consolidated with the sensory suggested immobilization test. Assessments included nerve conduction studies (NCS), Utah Early Neuropathy Scale (UENS), QST, and IVCCM, with automated determination of corneal nerve fiber length (CNFL) and branch density (CNBD) from wide-area mosaics of the subbasal nerve plexus. Plasma neurofilament light (p-NfL) was determined as a measure of axonal degeneration. No significant differences were found between groups when comparing CNFL (p = 0.81), CNBD (p = 0.92), NCS (p = 0.82), and QST (minimum p = 0.54). UENS scores, however, differed significantly (p = 0.001), with post-hoc pairwise testing revealing higher scores in both PD groups relative to controls (p = 0.018 and p = 0.001). Analysis of all PD patients (n = 42) revealed a correlation between the duration of L-dopa therapy and CNBD (ρ = -0.36, p = 0.022), and p-NfL correlated with UENS (ρ = 0.35, p = 0.026) and NCS (ρ = -0.51, p = 0.001). Small and large fiber neuropathy do not appear to be associated with RLS in PD. Whether peripheral small and/or large fiber pathology associates with central neurodegeneration in PD merits further longitudinal studies.

Entities:  

Year:  2021        PMID: 33402694      PMCID: PMC7785738          DOI: 10.1038/s41531-020-00148-5

Source DB:  PubMed          Journal:  NPJ Parkinsons Dis        ISSN: 2373-8057


  48 in total

1.  Levodopa, methylmalonic acid, and neuropathy in idiopathic Parkinson disease.

Authors:  Cory Toth; Kim Breithaupt; Shaohua Ge; Yanjun Duan; Joan M Terris; Anita Thiessen; Samuel Wiebe; Douglas W Zochodne; Oksana Suchowersky
Journal:  Ann Neurol       Date:  2010-07       Impact factor: 10.422

2.  Peripheral neuropathy as marker of severe Parkinson's disease phenotype.

Authors:  Aristide Merola; Michela Rosso; Alberto Romagnolo; Cristoforo Comi; Alfonso Fasano; Maurizio Zibetti; José Ricardo Lopez-Castellanos; Dario Cocito; Leonardo Lopiano; Alberto J Espay
Journal:  Mov Disord       Date:  2017-05-08       Impact factor: 10.338

3.  Suggested immobilization test for diagnosis of restless legs syndrome in Parkinson's disease.

Authors:  Valérie Cochen De Cock; Sophie Bayard; Huan Yu; Magda Grini; Bertrand Carlander; Ron Postuma; Mahmoud Charif; Yves Dauvilliers
Journal:  Mov Disord       Date:  2012-03-21       Impact factor: 10.338

4.  Neuropathy in Parkinson disease: prevalence and determinants.

Authors:  Yusuf A Rajabally; Jean Martey
Journal:  Neurology       Date:  2011-11-02       Impact factor: 9.910

5.  Profile of altered brain iron acquisition in restless legs syndrome.

Authors:  James R Connor; Padmavathi Ponnuru; Xin-Sheng Wang; Stephanie M Patton; Richard P Allen; Christopher J Earley
Journal:  Brain       Date:  2011-03-11       Impact factor: 13.501

6.  Restless legs syndrome in Parkinson's disease.

Authors:  Cecilia M Peralta; Birgit Frauscher; Klaus Seppi; Elisabeth Wolf; Gregor K Wenning; Birgit Högl; Werner Poewe
Journal:  Mov Disord       Date:  2009-10-30       Impact factor: 10.338

Review 7.  Restless legs syndrome in Parkinson's disease.

Authors:  Roselyne M Rijsman; Louise F Schoolderman; Rob S Rundervoort; Maartje Louter
Journal:  Parkinsonism Relat Disord       Date:  2014-01       Impact factor: 4.891

8.  Altered dopaminergic profile in the putamen and substantia nigra in restless leg syndrome.

Authors:  James R Connor; Xin-Sheng Wang; Richard P Allen; John L Beard; Jason A Wiesinger; Barbara T Felt; Christopher J Earley
Journal:  Brain       Date:  2009-05-25       Impact factor: 13.501

9.  Wide-field corneal subbasal nerve plexus mosaics in age-controlled healthy and type 2 diabetes populations.

Authors:  Neil S Lagali; Stephan Allgeier; Pedro Guimarães; Reza A Badian; Alfredo Ruggeri; Bernd Köhler; Tor Paaske Utheim; Beatrice Peebo; Magnus Peterson; Lars B Dahlin; Olov Rolandsson
Journal:  Sci Data       Date:  2018-04-24       Impact factor: 6.444

10.  Large-Fiber Neuropathy in Parkinson's Disease: Clinical, Biological, and Electroneurographic Assessment of a Romanian Cohort.

Authors:  Oana Maria Vanta; Nicoleta Tohanean; Sebastian Pintea; Lacramioara Perju-Dumbrava
Journal:  J Clin Med       Date:  2019-09-24       Impact factor: 4.241

View more
  3 in total

1.  Semiautomated and Automated Quantitative Analysis of Corneal Sub-Basal Nerves in Patients With DED With Ocular Pain Using IVCM.

Authors:  Yu Zhang; Yaying Wu; Wenbo Li; Xiaodan Huang
Journal:  Front Med (Lausanne)       Date:  2022-02-11

2.  Real-time large-area imaging of the corneal subbasal nerve plexus.

Authors:  Stephan Allgeier; Andreas Bartschat; Sebastian Bohn; Rudolf F Guthoff; Veit Hagenmeyer; Lukas Kornelius; Ralf Mikut; Klaus-Martin Reichert; Karsten Sperlich; Nadine Stache; Oliver Stachs; Bernd Köhler
Journal:  Sci Rep       Date:  2022-02-15       Impact factor: 4.379

3.  Wide-field mosaics of the corneal subbasal nerve plexus in Parkinson's disease using in vivo confocal microscopy.

Authors:  Reza A Badian; Stephan Allgeier; Fabio Scarpa; Mattias Andréasson; Andreas Bartschat; Ralf Mikut; Alessia Colonna; Marco Bellisario; Tor Paaske Utheim; Bernd Köhler; Per Svenningsson; Neil Lagali
Journal:  Sci Data       Date:  2021-11-26       Impact factor: 6.444

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.